348BT(寄生原生动物），NR-1_Vaccinia virus

NR-53513??Trypanosoma brucei subsp. gambiense, 348BT(Parasitic Protozoa)|Trypanosoma brucei subsp. gambiense|348BT|-130°C or colder (Note: Do not under any circumstances store vials at temperatures warmer than -70°C. Storage under these conditions will result in the death of the culture.)|J RaperAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Trypanosoma brucei subsp. gambiense, Strain 348BT, NR-53513."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Trypanosoma brucei (T. brucei) subsp. gambiense, strain 348BT was isolated in 2006 from the cerebral spinal fluid of a human with African trypanosomiasis (sleeping sickness) before treatment in Mbuji-Mayi, Democratic Republic of Congo. T. brucei subsp. gambiense, strain 348BT was passaged twice in Grammomys surdaster mice and deposited to BEI Resources as a T. brucei subsp. gambiense type I strain. Strain 348BT is reported to contain two mutations replacing aquaglyceroporin (AQP) genes AQP2 and AQP3 with chimeric AQP2/3 genes associated with resistance to melarsoprol and pentamidine. Each vial of NR-53513 contains approximately 0.5 mL of culture in cryopreservative [5% dimethylsulfoxide (DMSO)].